Related Experiment Video
Updated: Jun 18, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Correlation between Alzheimer's Disease and Gastrointestinal Tract Disorders
Julia Kuźniar1, Patrycja Kozubek1, Magdalena Czaja1
1Student Scientific Group of Psychiatry, Faculty of Medicine, Wroclaw Medical University, 50-369 Wroclaw, Poland.
The gut microbiome and gastrointestinal diseases are linked to Alzheimer's disease (AD) progression. Alterations in gut bacteria may influence brain health, suggesting new therapeutic avenues like probiotics for AD.
Area of Science:
- Neuroscience
- Gastroenterology
- Microbiology
Background:
- Alzheimer's disease (AD) is a leading cause of global dementia, characterized by amyloid-β plaques, neurofibrillary tangles, and synaptic loss.
- The multifactorial pathogenesis of AD is not fully understood, with emerging evidence linking the central nervous system to the gastrointestinal tract.
- The gut microbiome and gastrointestinal disorders are increasingly implicated in AD onset and progression.
Purpose of the Study:
- To explore the association between gastrointestinal health, the gut microbiome, and Alzheimer's disease.
- To investigate the mechanisms by which gut dysbiosis and inflammation may contribute to AD pathogenesis.
- To identify potential therapeutic strategies targeting the gut microbiome for AD management.
Main Methods:
- Review of studies examining the link between AD and gastrointestinal diseases (periodontitis, H. pylori infection, IBS).
- Analysis of the role of the gut microbiome and the microbiota-gut-brain axis in central nervous system function.
- Exploration of the impact of gut inflammation and permeability on AD pathology.
Main Results:
- Positive associations found between AD and conditions like periodontitis, H. pylori infection, and inflammatory bowel disease.
- Gut microbiome alterations (quantity and diversity) are observed in AD patients, even preclinically.
- Mechanisms include H. pylori entry into the CNS, systemic inflammation from periodontitis, and increased intestinal permeability contributing to neuroinflammation.
Conclusions:
- The gut microbiome and gastrointestinal tract play a significant role in Alzheimer's disease pathogenesis.
- Inflammation and microbial metabolites traversing the microbiota-gut-brain axis are key contributors to AD progression.
- Therapeutic interventions targeting the gut microbiome, such as antibiotics, probiotics, prebiotics, and fecal transplantation, show promise for AD treatment.
More Related Videos
Related Concept Videos
Other Disorders of Digestive System
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Alzheimer's Disease: Treatment
Gastrointestinal Motility Disorders
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...

